Amino acid replacement: L235P.
TT20433795CC
L257P | Psn-PA; L257P | Psn-PB; L257P | Psn-PC; L257P | Psn-PD; L257P | Psn-PE
Analogous L235P mutation in human PSEN1 implicated in Alzheimer's disease 3; mutation carried on in vitro construct; site of nucleotide substitution in fly gene inferred by FlyBase curator based on reported amino acid change.
Flies carrying two copies of PsnL235P.Scer\UAS expressed under the control of Scer\GAL4GMR.PF have wild-type eyes. Flies carrying two copies of Psn+14.Scer\UAS expressed under the control of Scer\GAL4GMR.PF have a rough eye phenotype, which is enhanced if the flies are also carrying one copy of PsnL235P.Scer\UAS. Does not affect the eye phenotype of flies expressing rprGMR.PH when expressed under the control of Scer\GAL4GMR.PF.
PsnL235P.UAS, Scer\GAL4GMR.PF is an enhancer of increased cell death phenotype of Hsap\APP695.UAS, Scer\GAL4GMR.PF
PsnL235P.UAS, Scer\GAL4GMR.PF is an enhancer of eye photoreceptor cell phenotype of Hsap\APP695.UAS, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF/PsnL235P.UAS is a non-enhancer of phenotype of rprGMR.PH
Scer\GAL4GMR.PF/PsnL235P.UAS is a non-suppressor of phenotype of rprGMR.PH
Coexpression of PsnL235P.Scer\UAS with Hsap\APP695.Scer\UAS, under the control of Scer\GAL4GMR.PF, enhances the degeneration.